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Letters to the Editor 369nosis) was demonstrated in 63 (38.4%) patients, followed by
sialoadenitis in 16 (9.8%) and mucoepidermoid carcinoma in
nine (5.5%) patients.
MSG tuberculosis was diagnosed in five (3%) patients by
either histopathologic study or mycobacterium tuberculosis
PCR.Theirmeanagewas37.4 (range25—49)years.All patients
were female and midwives. The involved MSG was the sub-
mandibular gland in four (80%) patients and the parotid gland
in only one (20%) patient. None of the patients had a past or
family history of TB. Physical examination was unremarkable
except for the presence of MSG masses. All patients received
standard anti-tuberculous chemotherapy for 8—12 months.
Iran is an endemic country for TB, so it is important to have
an estimate of TB prevalence in MSGmasses. To the best of our
knowledge, this is the first formal report in this regard. A
recent study in South Korea reported eight cases of MSG
tuberculosis among patients admitted at any of the three
tertiary referral centers in a period of 10 years.11 The parotid
and submandibular glands were involved in five (62.5%) and
three cases (37.5%), respectively. Another study found only
one case of salivary gland TB among 150 patients with salivary
gland disease in a 14-year experience in India.12 TB involve-
ment was located in a minor salivary gland in that study. In
another study of 155 salivary gland masses, 10 (6.4%) cases of
TB infection were found.13 A study in Turkey reported parotid
involvement of TB in six cases among 216 patients with a
parotid mass.14 Finally, in a 12-year study in China, nine
patients were reported to have suffered from tuberculosis
of the parotid glands.15 The prevalence of MSG tuberculosis in
our study is relatively similar to that in other reports fromAsia.
Considering the extremely rare event of tuberculous
involvement of the submandibular gland,3,4 our experience
is unusual in that 80% of our patients had their submandibular
glands involved. We doubt that this unusually high rate of
submandibular gland tuberculosis could be regarded as inci-
dental. However, we are at present unclear as to themechan-
ism of TB’s strong tendency to involve the submandibular
glands in our patients. Studies with larger sample sizes are
needed to clarify the significance of this finding.
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pyogenic liver abscess in community-acquired
Klebsiella pneumoniae bacteremia
Klebsiella pneumoniae is a leading cause of pyogenic liver
abscess (PLA) in some Asian countries,1—5 where one of the
most common sources of K. pneumoniae bacteremia is PLA.6—8PLA presents a diagnostic challenge, because half of all
patients show no specific symptoms or signs that direct atten-
tion to the liver. This study was conducted to identify clinical
and laboratory factors indicating the early diagnosis of PLA in
community-acquired K. pneumoniae bacteremia.
Patients at three hospitals in Korea, diagnosed with K.
pneumoniae bacteremia between January 2001 and Decem-
ber 2004, were retrospectively reviewed with regard to
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Table 1 Clinical characteristics of patients with community-acquired Klebsiella pneumoniae bacteremiaa
Variables PLA group (N = 38) Non-PLA group (N = 93) p Value
Age (mean  standard deviation) years 62.1  12.9 62.2  13.8 1.0
Male:female 1.2 1.3 0.9
Underlying conditions
Pancreaticobiliary disease including tumor 7 (18.4%) 27 (29.0%) 0.2
Liver cirrhosis with/without hepatoma 0 12 (12.9%) 0.02
Diabetes mellitus 9 (23.7%) 25 (26.9%) 0.7
None 25 (65.8%) 41 (44.1%) 0.04
Symptoms
Right upper quadrant pain 9 (23.7%) 28 (30.1%) 0.5
Physical findings
Body temperature >38 or <36 8C 24 (63.2%) 54 (58.1%) 0.6
Hepatomegaly 1 (2.6%) 4 (4.3%) 1.0
Laboratory findings
White cell count >12 or <4  109/l 19 (50.0%) 45 (48.4%) 0.9
Platelet <100  109/l 16 (42.1%) 33 (35.5%) 0.5
C-reactive protein >10 mg/dl 28/35 (80.0%) 49/74 (66.2%) 0.1
Alanine transaminase >100 U/L 17 (44.7%) 34 (36.6%) 0.4
Albumin <3 g/dl 15/37 (40.5%) 39/90 (43.3%) 0.8
Total bilirubin >1.5 mg/dl 14 (36.8%) 58 (62.4%) 0.008
Alkaline phosphatase >300 U/L 3/37 (8.1%) 8/89 (9.0%) 1.0
Lactate dehydrogenase >400 U/L 22/27 (81.5%) 32/61 (52.5%) 0.01
Chest X-ray abnormalities b 6 (15.8%) 13 (14.0%) 0.8
Severity of illness
SAPS II score of 30 8 (21.1%) 24 (25.8%) 0.57
Septic shock 5 (13.2%) 12 (12.9%) 1.0
SAPS, simplified acute physiology score.
a Not all parameters are presented.
b Chest X-ray abnormalities in the right lower lung field included pleural effusion, atelectasis, or elevated right hemidiaphragm.demographic, clinical, and laboratory data. Healthcare-asso-
ciated and nosocomial cases were excluded because K.
pneumoniae bacteremia associated PLA is usually commu-
nity-acquired.1 Only community-acquired cases in adults who
had undergone abdominal ultrasonography (US) or computed
tomography (CT) were included. The severity of acute illness
was assessed at the time of initial bacteremia by using the
simplified acute physiology score (SAPS) II.9
Among a total of 311 adult patients with K. pneumoniae
bacteremia, 131 met the inclusion criteria and were ana-
lyzed. In 38 of the 131 patients, K. pneumoniae bacteremia
was associated with PLA (PLA group). PLAwas cryptogenic in
31 patients and of biliary origin in seven. In 93 patients
(non-PLA group), the sources of bacteremia were biliary
tract (49), unknown source (17), urinary tract (16), lung (5),
peritoneum (3), bone and joint (2), and skin and soft tissue
(1). Bacteremia was polymicrobial in five patients only, in
the non-PLA group ( p = 0.32). Clinical characteristics are
compared in Table 1. Multiple logistic regression revealed
that only hyperbilirubinemia (total bilirubin >1.5 mg/dl)
was negatively associated with PLA (odds ratio 0.16; 95%
confidence interval 0.04—0.73; p = 0.02). Diabetes mellitus
and pancreaticobiliary disease were the most common
underlying conditions in our patients, but no significant
difference was found between the PLA group and non-
PLA group. Several symptoms including fever, chills,
malaise, myalgia, and headache were found to be signifi-cantly associated with PLA by univariate analysis. Hepato-
megaly and right upper quadrant pain were more commonly
found in non-PLA patients, but without statistical signifi-
cance. It might be because more than half of all non-PLA
patients had biliary tract infections. Some laboratory para-
meters, i.e., hemoglobin, total bilirubin, and lactate dehy-
drogenase, were positively or negatively associated with
the presence of PLA by univariate analysis, but only hyper-
bilirubinemia was negatively associated with PLA by multi-
variate analysis. Even though such laboratory abnormalities
could suggest hepatic abnormalities, these were not uni-
formly specific for the presence of PLA in patients with
community-acquired K. pneumoniae bacteremia.
In summary, although several clinical and laboratory find-
ings were significantly associated with PLA in this study, we
could not derive consistent clues for the presence of PLA
because of their non-specificity. Therefore, in regions where
K. pneumoniae is a common cause of bacteremic PLA,
abdominal imaging studies should be obtained to rule out
PLA in adults without an explainable source of community-
acquired K. pneumoniae bacteremia.Acknowledgements
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doi:10.1016/j.ijid.2006.09.008Recurrent catheter-related bloodstream infec-
tions: risk factors and outcome
With considerable interest we read the article by Erbay et al.,
in which the authors examined the risk factors for recurrent
catheter-related bloodstream infections (CR-BSI).1 Although
Erbay et al. also included general ward patients in their
analyses, they found an astonishingly high rate of patients
with recurrent CR-BSI.1 In our opinion this enormous inci-
dence, namely one-third of patients, can firstly be explained
by their definitions; they define recurrent CR-BSI as positive
blood cultures, coupled with positive catheter tip culture ‘or’
no other new source of infection evident. Secondly, it is
conceivable that patients admitted to the intensive care
unit are more prone to non-infectious signs of systemic
inflammation compared to those admitted elsewhere in
the hospital. However, we would have liked the authors to
detail the indications for which blood sampling for culturing
was obtained.
CR-BSI should be treated with systemic antimicrobials for
10—14 days.2 In the article by Erbay et al., no data are given
concerning the time period in which antimicrobials were
administered. Consequently, it may be assumed that some
of the CR-BSIs, now categorized as ‘recurrent CR-BSI’, were
still related to the first episode. Further, it was mentioned
that all patients were given antibiotics; however, no infor-
mation was provided concerning the time delay to the start ofadequate antimicrobials. As appropriateness of empiric anti-
microbial therapy within the first hours following onset of
infection is of key importance to the improvement of patient
outcome, we would be interested in an elaboration of this
issue.3—5
CR-BSIs place a significant burden on healthcare resources
due to the necessity for additional therapies. The increased
morbidity accounts for a significant increase in healthcare
expenditure.6 We congratulate Dr Erbay and colleagues for
their important work at aiming to identify risk factors related
to the development of recurrent CR-BSIs. However, the most
important risk factor for CR-BSI is transmission by means of
the personnel taking care of the patient. Therefore, in
addition to their research, we would like to draw attention
to the fact that the cornerstone of CR-BSI prevention is
education, with performance feedback and on-the-floor pro-
cess control following on.7 As CR-BSIs are largely preventable
nosocomial infections, an intensified teaching program may
heighten awareness among healthcare professionals, so that
standards will become routine.8 It has been proven that this is
one of the most effective, easiest, and least expensive
strategies to reduce CR-BSI rates.9,10 Ultimately, taking full
advantage of knowledge of associated risk factors of CR-BSIs,
in combination with fitting strategies such as education
programs, will lead to reduced antibiotic use and thus alle-
viation of selection pressure.
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